Metabolic Health
Semaglutide's Second Act: Beyond Weight Loss to Liver, Skin, and Inflammation
New 2025 data hints that GLP-1 drugs may quiet inflammation in the liver and skin — but a sober pharmacology review reminds us the price tag, and the science, are still catching up.